Ken Griffin Citadel Advisors
Ken Griffin founded Citadel, one of the world’s largest and most successful hedge funds. Starting his trading career from his Harvard dorm room at a young age, Griffin quickly developed a keen sense for markets and built Citadel into a global powerhouse with billions in assets under management. Known for his quantitative and technology-driven strategies, Griffin has also made headlines for significant philanthropic contributions, supporting causes in education, the arts, and public institutions. Over the years, he has earned recognition as one of the preeminent figures in modern finance.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$555M |
| 2 |
Citigroup
C
|
+$407M |
| 3 |
Medtronic
MDT
|
+$401M |
| 4 |
Chipotle Mexican Grill
CMG
|
+$392M |
| 5 |
Gilead Sciences
GILD
|
+$362M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Invesco QQQ Trust
QQQ
|
+$1.43B |
| 2 |
Amazon
AMZN
|
+$1.32B |
| 3 |
Apple
AAPL
|
+$1.1B |
| 4 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$995M |
| 5 |
Bank of America
BAC
|
+$726M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 3.02% |
| 2 | Healthcare | 2.92% |
| 3 | Consumer Discretionary | 2.17% |
| 4 | Financials | 2.1% |
| 5 | Industrials | 1.63% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
11001
CALL
KT
KT
$9.11B
| $103K | ﹤0.01% |
6,700
+5,200
| +347% | +$75K |
|
11002
CALL
Invesco S&P SmallCap Energy ETF
PSCE
$106M
| $103K | ﹤0.01% |
2,100
+2,000
| +2,000% | +$103K |
|
|
NVEE
11003
CALL
DELISTED
NV5 Global
NVEE
| $103K | ﹤0.01% |
4,400
-800
| -15% | -$19K |
|
11004
CALL
Atossa Therapeutics
ATOS
$25.9M
| $103K | ﹤0.01% |
4,507
+1,667
| +59% | +$33.7K |
|
11005
CALL
Atlas Lithium Corp
ATLX
$94.7M
| $103K | ﹤0.01% |
15,100
+2,000
| +15% | +$20.3K |
|
11006
CALL
Vanguard Morningstar Mega Cap Value ETF
MGV
$13.8B
| $103K | ﹤0.01% |
800
+600
| +300% | +$74.1K |
|
11007
CALL
Stagwell
STGW
$2.23B
| $102K | ﹤0.01% |
+14,600
| New | +$100K |
|
11008
PUT
Rigel Pharmaceuticals
RIGL
$795M
| $102K | ﹤0.01% |
6,320
+3,130
| +98% | +$36.8K |
|
|
HTB
11009
CALL
HomeTrust Bancshares
HTB
$834M
| $102K | ﹤0.01% |
+3,000
| New | +$101K |
|
11010
CALL
BARK
BARK
$91.4M
| $102K | ﹤0.01% |
3,135
+760
| +32% | +$24.7K |
|
11011
PUT
Odyssey Marine Exploration
OMEX
$52.9M
| $102K | ﹤0.01% |
123,300
+102,200
| +484% | +$384K |
|
11012
CALL
Bankunited
BKU
$3.44B
| $102K | ﹤0.01% |
2,800
-7,700
| -73% | -$273K |
|
|
HTT
11013
PUT
High Templar Tech Ltd
HTT
$393M
| $102K | ﹤0.01% |
47,900
+46,800
| +4,255% | +$86.5K |
|
|
INCR
11014
Intercure
INCR
$58.6M
| $102K | ﹤0.01% |
50,712
-582
| -1% | -$1.22K |
|
|
UBX
11015
DELISTED
Unity Biotechnology
UBX
| $102K | ﹤0.01% |
69,210
-2,998
| -4% | -$4.4K |
|
|
TOUR
11016
Tuniu
TOUR
$53.2M
| $102K | ﹤0.01% |
7,158
-9,090
| -56% | -$79.1K |
|
11017
PUT
BBVA Argentina
BBAR
$3.13B
| $102K | ﹤0.01% |
9,800
+3,800
| +63% | +$37.3K |
|
|
PCF
11018
High Income Securities Fund
PCF
$102M
| $102K | ﹤0.01% |
+14,877
| New | +$98.9K |
|
11019
CALL
iShares MSCI EAFE Small-Cap ETF
SCZ
$13.6B
| $102K | ﹤0.01% |
+1,500
| New | +$96.5K |
|
11020
PUT
AMERISAFE
AMSF
$513M
| $101K | ﹤0.01% |
2,100
| – | – |
|
|
JBIO
11021
CALL
Jade Biosciences
JBIO
$1.57B
| $101K | ﹤0.01% |
1,386
+1,069
| +337% | +$69K |
|
11022
CALL
AC Immune
ACIU
$248M
| $101K | ﹤0.01% |
26,800
+13,900
| +108% | +$48.5K |
|
|
AIV
11023
PUT
Aimco
AIV
$383M
| $101K | ﹤0.01% |
11,200
+8,700
| +348% | +$77.3K |
|
11024
CALL
SelectQuote
SLQT
$129M
| $101K | ﹤0.01% |
46,600
+39,500
| +556% | +$130K |
|
11025
HF Foods Group
HFFG
$99.2M
| $101K | ﹤0.01% |
28,319
-38,707
| -58% | -$126K |
|
Similar funds
Ken Griffin's Q3 2024 Portfolio in Review
As of Q3 2024, Ken Griffin held 15,731 positions worth $518B, up 4.9% from $494B the previous quarter. Its ten largest holdings account for 30% of the portfolio.
Ken Griffin's Q3 2024 filing shows 1,614 new, 6,434 increased, 5,866 reduced and 1,610 closed positions. Its largest new stake was iShares 7-10 Year Treasury Bond ETF: 2,002,737 shares worth $197M. The largest sale was Invesco QQQ Trust, an estimated $1.43B.
By sector, the portfolio is most concentrated in Technology at 3% of assets, down from 3.4% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- Ken Griffin's largest Q3 2024 buy was iShares 7-10 Year Treasury Bond ETF: 2,002,737 shares worth $197M.
- Ken Griffin added most to NVIDIA in Q3 2024, an estimated $555M increase.
- Ken Griffin's biggest Q3 2024 reduction was Invesco QQQ Trust, cutting an estimated $1.43B.
- Ken Griffin fully exited Domino's in Q3 2024, selling an estimated $186M.
- Ken Griffin's ten largest holdings make up 30% of its $518B portfolio in Q3 2024.
- Ken Griffin opened 1,614 new positions and closed 1,610 in Q3 2024.
- Ken Griffin's portfolio value rose 4.9% quarter-over-quarter to $518B.
Based on Citadel Advisors's 13F filing for Q3 2024, filed 14 Nov 2024.